Speaker illustration

Associate Professor Marko Banovic

Clinical center of Serbia, Belgrade (Serbia)

Member of:

European Society of Cardiology

Asst Professor, MD, MSc (2008), PhD (2012), FESC, FACC, consultant cardiologist at the Cardiology Dpt, University Clinical Center of Serbia, Belgrade, Serbia Former Mayo Clinic alumni (echocardiography laboratory 2007, 2008, 2010) Performing both non-invasive and interventional cardiology. Special interest is in valve disease and regenerative and device-related treatment of heart failure. Winner of MEDIS international scientific award 2015, Paul Dudley White Scientific Award at AHA congress 2018, Servier Advanced Cardiovascular School award (2016-2017). Received award as a student from the Government of the Kingdom of Norway. Had a Scholarship from Konrad Adenauer Stiftung. Graduated from Belgrade medical School 9.77/10. More than 50 in-extenso cc/ papers with IF published of which > 35 as a first/corresponding author Author and Principal Investigator for the multinational randomized Avatar trial. Founder and co-director of the Belgrade Valve International Symposium (BELVIS)

Gender specific differences in functional capacity in asymptomatic patients with isolated severe aortic stenosis

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Diagnostic Methods

Session: Valvular Heart Disease ePosters


Predictive value of ve/vco2 slope in discovering hfpef during combined cardiopulmonary/stress-echocardiography testing in patients with hypertension and normal systolic and diastolic function at rest

Event: ESC CONGRESS 2017

Topic: Heart failure, other

Session: Acute heart failure (AHF)


Masked hfpef in hypertensive patients with normal systolic and diastolic function at rest is more frequent in diabetic: a role of combined cardiopulmonary and stress-echocardiography testing

Event: ESC CONGRESS 2017

Topic: Diastolic dysfunction

Session: Chronic heart failure (CHF)


Long-term risk stratification with low-dose dobutamine testing in asymptomatic low-flow patients with severe aortic stenosis and normal ejection fraction

Event: ESC CONGRESS 2016

Topic: Aortic valve disease

Session: Valvular disease


This platform is supported by

logo Novo Nordisk